Market Research Report - 230997
Triple Analysis: Breast Cancer, Angiogenesis and Protein Kinase Inhibitors
|Published by||BioSeeker Group AB|
|Published||Content info||6399 Pages|
|Triple Analysis: Breast Cancer, Angiogenesis and Protein Kinase Inhibitors|
|Published: August 1, 2012||Content info: 6399 Pages||
This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas.